Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Inna Sekirov

Showing results (61-70 of 69) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 69 results.
Canada Communicable Disease Report = Releve Des Maladies Transmissibles Au Canada|May 26, 2021
Practical guidance for clinical laboratories for SARS-CoV-2 serology testingCarmen Charlton, Jamil Kanji, Vanessa Tran, et al.
BMC Infectious Diseases|January 15, 2024
Factors associated with SARS-CoV-2 infection in unvaccinated children and young adultsSarah L Silverberg, Hennady P Shulha, Brynn McMillan, et al.
Medrxiv : the Preprint Server for Health Sciences|October 14, 2020
Antibody reactivity to SARS-CoV-2 is common in unexposed adults and infants under 6 monthsAbdelilah Majdoubi, Christina Michalski, Sarah E O'Connell, et al.
Frontiers in Immunology|October 11, 2021
Comprehensive Immune Profiling of a Kidney Transplant Recipient With Peri-Operative SARS-CoV-2 Infection: A Case ReportKaren R Sherwood, David D M Nicholl, Franz Fenninger, et al.
Scientific Reports|April 18, 2024
Adaptive immune responses to two-dose COVID-19 vaccine series in healthy Canadian adults ≥ 50 years: a prospective, observational cohort studyGabrielle N Gaultier, Brynn McMillan, Chad Poloni, et al.
JCI Insight|March 15, 2021
A majority of uninfected adults show preexisting antibody reactivity against SARS-CoV-2Abdelilah Majdoubi, Christina Michalski, Sarah E O'Connell, et al.
Microbiology Spectrum|November 17, 2021
Evaluating Humoral Immunity against SARS-CoV-2: Validation of a Plaque-Reduction Neutralization Test and a Multilaboratory Comparison of Conventional and Surrogate Neutralization AssaysEmelissa J Valcourt, Kathy Manguiat, Alyssia Robinson, et al.
Diagnostic Microbiology and Infectious Disease|August 23, 2021
Evaluation of commercial SARS-CoV-2 serological assays in Canadian public health laboratoriesDerek R Stein, Carla Osiowy, Ainsley Gretchen, et al.
Microbiology Spectrum|June 22, 2022
Correction for Valcourt et al., "Evaluating Humoral Immunity against SARS-CoV-2: Validation of a Plaque-Reduction Neutralization Test and a Multilaboratory Comparison of Conventional and Surrogate Neutralization Assays"Emelissa J Valcourt, Kathy Manguiat, Alyssia Robinson, et al.
Pageof 7

Showing results (61-70 of 69) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 69 results.
Canada Communicable Disease Report = Releve Des Maladies Transmissibles Au Canada|May 26, 2021
Practical guidance for clinical laboratories for SARS-CoV-2 serology testingCarmen Charlton, Jamil Kanji, Vanessa Tran, et al.
BMC Infectious Diseases|January 15, 2024
Factors associated with SARS-CoV-2 infection in unvaccinated children and young adultsSarah L Silverberg, Hennady P Shulha, Brynn McMillan, et al.
Medrxiv : the Preprint Server for Health Sciences|October 14, 2020
Antibody reactivity to SARS-CoV-2 is common in unexposed adults and infants under 6 monthsAbdelilah Majdoubi, Christina Michalski, Sarah E O'Connell, et al.
Frontiers in Immunology|October 11, 2021
Comprehensive Immune Profiling of a Kidney Transplant Recipient With Peri-Operative SARS-CoV-2 Infection: A Case ReportKaren R Sherwood, David D M Nicholl, Franz Fenninger, et al.
Scientific Reports|April 18, 2024
Adaptive immune responses to two-dose COVID-19 vaccine series in healthy Canadian adults ≥ 50 years: a prospective, observational cohort studyGabrielle N Gaultier, Brynn McMillan, Chad Poloni, et al.
JCI Insight|March 15, 2021
A majority of uninfected adults show preexisting antibody reactivity against SARS-CoV-2Abdelilah Majdoubi, Christina Michalski, Sarah E O'Connell, et al.
Microbiology Spectrum|November 17, 2021
Evaluating Humoral Immunity against SARS-CoV-2: Validation of a Plaque-Reduction Neutralization Test and a Multilaboratory Comparison of Conventional and Surrogate Neutralization AssaysEmelissa J Valcourt, Kathy Manguiat, Alyssia Robinson, et al.
Diagnostic Microbiology and Infectious Disease|August 23, 2021
Evaluation of commercial SARS-CoV-2 serological assays in Canadian public health laboratoriesDerek R Stein, Carla Osiowy, Ainsley Gretchen, et al.
Microbiology Spectrum|June 22, 2022
Correction for Valcourt et al., "Evaluating Humoral Immunity against SARS-CoV-2: Validation of a Plaque-Reduction Neutralization Test and a Multilaboratory Comparison of Conventional and Surrogate Neutralization Assays"Emelissa J Valcourt, Kathy Manguiat, Alyssia Robinson, et al.
Pageof 7